Here's Why Cardinal Health (CAH) is a Strong Momentum Stock

Oct 16, 2024 · CAH boasts a Momentum Style Score of B and VGM Score of A, and holds a Zacks Rank #2 (Buy) rating. Shares of Cardinal Health has seen some interesting price action …

5%
OFF

Cardinal Health Share Reaffirms Neutral Rating On Outlook

2 weeks from now

2 days ago · On Tuesday, Citi analyst confirmed a Neutral rating and a $129.00 price target for Cardinal Health (NYSE: CAH) stock, which has shown impressive momentum with a 29.5% …

investing.com

55%
OFF

Cardinal Health (CAH) Increases Yet Falls Behind Market: What

2 weeks from now

Cardinal Health (CAH) ended the recent trading session at $124.71, demonstrating a +0.55% swing from the preceding day's closing price. The stock's performance was behind the S&P …

msn.com

4%
OFF

Why Cardinal Health (CAH) Is A Top Momentum Stock For The …

2 weeks from now

Sep 17, 2024 · CAH is a Zacks Rank #3 (Hold) stock, with a Momentum Style Score of B and VGM Score of A. Shares are up 0.4% over the past one week and up 3.2% over the past four …

yahoo.com

2%
OFF

Here's Why You Should Add Glaukos Stock To Your Portfolio Now

2 weeks from now

6 days ago · CAH’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 11.2%. You can see the complete list of today’s Zacks #1 Rank …

tradingview.com

3%
OFF

Capital Investment Advisors LLC Sells 20,151 Shares Of Cardinal …

2 weeks from now

3 days ago · Capital Investment Advisors LLC cut its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 14.3% during the fourth quarter, according to the company in its most recent …

marketbeat.com

FAQs about Here's Why Cardinal Health (CAH) is a Strong Momentum Stock Coupon?

Is Cardinal Health (CAH) a good stock to buy?

Headquartered in Dublin, OH, Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments – Pharmaceutical and Medical. CAH boasts a Momentum Style Score of A and VGM Score of A, and holds a Zacks Rank #2 (Buy) rating. ...

Is Cardinal Health a good company?

Should you buy Cardinal Health (CAH) in 2025?

Gain essential insights for 2025. Cardinal Health gets downgraded to a hold, from my buy rating last February, agreeing with the Seeking Alpha quant system rating. While macro-level demand for medical supplies is expected to keep growing, CAH is plagued by negative equity. ...

What are the Zacks consensus estimates for Cardinal Health?

For the annual period, the Zacks Consensus Estimates anticipate earnings of $7.82 per share and a revenue of $219.02 billion, signifying shifts of +3.85% and -3.51%, respectively, from the last year. Investors might also notice recent changes to analyst estimates for Cardinal Health. ...

How did Cardinal Health (CAH) perform?

Cardinal Health (CAH) ended the recent trading session at $124.71, demonstrating a +0.55% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1.83%. Elsewhere, the Dow gained 1.65%, while the tech-heavy Nasdaq added 2.45%. ...

Is Cardinal a good stock to buy?

Therefore, within this sector, Cardinal offers a modest yield compared to similar peers. It also has a payout ratio of just 26%, meaning that over 3/4ths of profits are not used for dividend payments but other things, which may leave more cash for repurchasing of shares and that could also support the share price. ...